IP Library Granted Patent US 12,582,829
Granted Patent B2
US 12,582,829 · App. 17/600,516 · Granted Mar 24, 2026

Plasma treatment devices and methods of use thereof

Inventors: Michael Fourkas (Sunnyvale, CA); Denis O'Sullivan (Dungarvan, IE); Liam O'Neill (Midleton, IE); Joseph M. Tartaglia (Morgan Hill, CA)
Assignee: TheraDep Technologies, Inc.
A61N1/44A61M11/02H05H1/48H05H2245/32H05H2245/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,582,829
App. No.
17/600,516
Granted
Mar 24, 2026
Kind
B2
Abstract

Medical devices for generating an aerosol and plasma, e.g., for therapeutic treatment are described. The medical device may include a nebulizer, the nebulizer including an outer compartment, an inner compartment, and a needle radially inward of the inner and outer compartments. The medical device may include at least one electrode and a chamber, wherein a distal-facing surface of the chamber defines at least one plasma outlet and a nozzle in communication with the nebulizer, an end of the electrode being proximate the plasma outlet.

Claims (71)

1 . A medical device comprising:

a housing that includes a nebulizer, the nebulizer comprising:

an outer compartment in communication with a gas inlet,

an inner compartment in communication with a fluid channel and a fluid inlet, and

a needle;

wherein the needle is radially inward of the inner compartment, the inner compartment is radially inward of the outer compartment, and a distal end of the outer compartment is in communication with a distal end of the inner compartment;

at least one electrode; and

a chamber defined by a distal end portion of the housing;

wherein a distal-facing surface of the chamber defines at least one plasma outlet and a nozzle in communication with the nebulizer; and

wherein an end of the at least one electrode is proximate the plasma outlet, and wherein a proximal portion of the chamber is configured to receive an electrode tip of a plasma device and to electrically connect the electrode tip of the plasma device to the at least one electrode.

2 . The medical device of claim 1 , wherein a longitudinal position of the needle of the nebulizer is adjustable.

3 . The medical device of claim 1 , wherein a distal portion of the housing includes an actuator configured to control the flow of a gas to the gas inlet.

4 . The medical device of claim 3 , further comprising the plasma device, wherein the actuator of the housing is arranged relative to an actuator of the plasma device so as to allow a user to control the flow of gas and to power the plasma device simultaneously.

5 . The medical device of claim 1 , further comprising a fluid reservoir coupled to the fluid inlet.

6 . The medical device of claim 5 , wherein the fluid reservoir includes mating elements complementary to mating elements of the fluid inlet, such that the fluid reservoir is selectively detachable from the fluid inlet.

7 . The medical device of claim 5 , wherein the fluid reservoir contains a liquid that comprises at least one therapeutic agent.

8 . The medical device of claim 7 , wherein the at least one therapeutic agent comprises a biomolecule, a pharmaceutical agent, or a combination thereof.

9 . The medical device of claim 7 , wherein the at least one therapeutic agent is dissolved in a solvent.

10 . The medical device of claim 1 , wherein the housing defines a first channel in communication with the outer compartment of the nebulizer and a second channel that contains the at least one electrode, a distal end of the second channel defining the plasma outlet.

11 . The medical device of claim 1 , wherein the at least one electrode extends through a wall of the chamber.

12 . A medical device comprising:

a housing that includes a nebulizer, the nebulizer comprising:

an outer compartment,

an inner compartment, and

a needle;

wherein the needle is radially inward of the inner compartment, the inner compartment is radially inward of the outer compartment, and a distal end of the outer compartment is in communication with a distal end of the inner compartment;

a fluid reservoir coupled to a fluid inlet, the fluid reservoir containing a liquid that comprises at least one therapeutic agent;

at least one electrode; and

a chamber defined by a distal end portion of the housing;

wherein a distal-facing surface of the chamber defines at least one plasma outlet and a nozzle in communication with the nebulizer; and

wherein an end of the at least one electrode is proximate the plasma outlet; and

wherein a proximal portion of the chamber is configured to receive an electrode tip of a plasma device and to electrically connect the electrode tip of the plasma device to the at least one electrode.

13 . The medical device of claim 12 , wherein the fluid reservoir includes mating elements complementary to mating elements of the fluid inlet, such that the fluid reservoir is selectively detachable from the fluid inlet.

14 . The medical device of claim 12 , wherein the fluid reservoir is permanently attached to the fluid inlet.

15 . The medical device of claim 12 , wherein the outer compartment of the nebulizer is in communication with a gas inlet, and the inner compartment of the nebulizer is in communication with the fluid inlet.

16 . The medical device of claim 12 , wherein the end of the at least one electrode is recessed from the distal-facing surface of the chamber.

17 . The medical device of claim 12 , wherein the housing defines a first channel in communication with the outer compartment of the nebulizer and a second channel that contains the at least one electrode, a distal end of the second channel defining the plasma outlet.

18 . The medical device of claim 12 , wherein the at least one therapeutic agent comprises a biomolecule, a pharmaceutical agent, or a combination thereof.

19 . A medical device comprising:

a housing that includes a nebulizer, the nebulizer comprising:

an outer compartment in communication with a gas inlet,

an inner compartment in communication with a fluid inlet, and

a needle;

wherein the needle is radially inward of each of the inner compartment and the outer compartment, and a distal end of the outer compartment is in communication with a distal end of the inner compartment;

at least one electrode;

a fluid reservoir coupled to the fluid inlet; and

a chamber defined by a distal end portion of the housing;

wherein a distal-facing surface of the chamber defines at least one plasma outlet and a nozzle in communication with the nebulizer; and

wherein an end of the at least one electrode is proximate the plasma outlet; and

wherein a proximal portion of the chamber is configured to receive an electrode tip of a plasma device and to electrically connect the electrode tip of the plasma device to the at least one electrode.

20 . A method of treating tissue of a subject, the method comprising exposing the tissue to plasma and an aerosol comprising at least one therapeutic agent using a medical device, the medical device comprising:

a housing that includes a nebulizer, the nebulizer comprising:

an outer compartment in communication with a gas inlet,

an inner compartment in communication with a fluid channel and a fluid inlet, wherein the fluid channel receives a fluid that comprises the at least one therapeutic agent, and

a needle;

wherein the needle is radially inward of the inner compartment, the inner compartment is radially inward of the outer compartment, and a distal end of the outer compartment is in communication with a distal end of the inner compartment;

at least one electrode; and

a chamber defined by a distal end portion of the housing;

wherein a distal-facing surface of the chamber defines at least one plasma outlet and a nozzle in communication with the nebulizer;

wherein an end of the at least one electrode is proximate the plasma outlet;

wherein a proximal portion of the chamber receives an electrode tip of a plasma device and electrically connects the electrode tip of the plasma device to the at least one electrode; and

wherein the plasma device generates the plasma and the nebulizer generates the aerosol exposed to the tissue.

21 . The method of claim 20 , wherein the tissue is internal tissue or external tissue.

22 . The method of claim 20 , wherein the tissue is part of a wound, burn, cut, ulcer, abrasion, or tumor.

23 . The method of claim 20 , wherein the subject is a human subject.

24 . The method of claim 20 , wherein the method comprises generating plasma at a frequency ranging from about 150 kHz to about 500 kHz.

25 . The method of claim 20 , wherein the at least one therapeutic agent comprises a biomolecule, a pharmaceutical agent, or a combination thereof.

26 . The method of claim 20 , wherein the at least one therapeutic agent comprises collagen.

27 . The method of claim 20 , wherein the method includes supplying the fluid to the nebulizer from a fluid reservoir and supplying power to the at least one electrode simultaneously, such that the aerosol exits the nozzle at the same time the plasma exits the plasma outlet.

28 . The method of claim 27 , wherein supplying the fluid and supplying the power includes pressing a single actuator of the medical device.

29 . The method of claim 28 , wherein pressing the single actuator engages a power button of the medical device aligned with the single actuator.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: FOURKAS, MICHAEL; O'SULLIVAN, DENIS; O'NEILL, LIAM; TARTAGLIA, JOSEPH M.
To: THERADEP TECHNOLOGIES, INC.
Reel/Frame 061638/0178 →
Continuity (2)
Provisional Application 62828797 · Apr 3, 2019
Related Publication 20220176140A1 · Jun 9, 2022
References Cited (23)
US 5554172A · Horner et al. · 1996 [cited by applicant]
US 20070006814A1 · Mead et al. · 2007 [cited by applicant]
US 20110101862A1 · Koo et al. · 2011 [cited by applicant]
US 20120089084A1 · O'Keeffe et al. · 2012 [cited by applicant]
US 20130218069A1 · Neugebauer et al. · 2013 [cited by applicant]
US 20150038790A1 · Ronta et al. · 2015 [cited by applicant]
US 20150366042A1 · Zaidi · 2015 [cited by applicant]
US 20170312376A1 · Bae · 2017 [cited by applicant]
US 20180296813A1 · Hoekman · 2018 [cited by examiner]
CN 101888860A · 2010 [cited by applicant]
CN 203763232U · 2014 [cited by applicant]
EP 1588730A1 · 2005 [cited by applicant]
EP 2765592A2 · 2014 [cited by applicant]
EP 3415172A1 · 2018 [cited by applicant]
JP H05245202A · 1993 [cited by applicant]
JP H10188877A · 1998 [cited by applicant]
JP 2008519411A · 2008 [cited by applicant]
JP 5245202B2 · 2013 [cited by applicant]
JP 2014212839A · 2014 [cited by applicant]
WO WO2009100383A2 · 2009 [cited by applicant]
WO 2011069135A1 · 2011 [cited by applicant]
O'Neill, L. et al., “Evaluation of the J-Plasma Electrosurgical Device Combined with Nebulized Collagen for Burn Healing in Rodents”, [cited by applicant]
International Search Report in PCT/US2020/025685 mailed Jun. 22, 2020 (4 pages). [cited by applicant]